The next board meeting for ProQR Therapeutics N.V is on 08 Aug 2025 for the purpose of ProQR Therapeutics NV Second Quarter Earnings Results for 2025See details
ProQR Therapeutics N.V has a share price target of US$ 9, revenue growth forecast of -7.1%, and profit growth estimate of -46.8% for FY25, based on top 8 analyst calls.